Xiaotian Yuan - Search Results

Year	Number of Results
2014	1
2015	1
2016	6
2017	4
2018	3
2019	6
2020	7
2021	0

1

Telomerase Reverse Transcriptase (TERT) in Action: Cross-Talking with Epigenetics.

Yuan X, Xu D. Yuan X, et al. Int J Mol Sci. 2019 Jul 7;20(13):3338. doi: 10.3390/ijms20133338. Int J Mol Sci. 2019. PMID: 31284662 Free PMC article. Review.

2

Telomere-related Markers for Cancer.

Yuan X, Dai M, Xu D. Yuan X, et al. Curr Top Med Chem. 2020;20(6):410-432. doi: 10.2174/1568026620666200106145340. Curr Top Med Chem. 2020. PMID: 31903880 Free PMC article. Review.

3

Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.

Yuan X, Larsson C, Xu D. Yuan X, et al. Oncogene. 2019 Aug;38(34):6172-6183. doi: 10.1038/s41388-019-0872-9. Epub 2019 Jul 8. Oncogene. 2019. PMID: 31285550 Free PMC article. Review.

4

GABPA is a master regulator of luminal identity and restrains aggressive diseases in bladder cancer.

Guo Y, Yuan X, Li K, Dai M, Zhang L, Wu Y, Sun C, Chen Y, Cheng G, Liu C, Strååt K, Kong F, Zhao S, Bjorkhölm M, Xu D. Guo Y, et al. Among authors: yuan x. Cell Death Differ. 2020 Jun;27(6):1862-1877. doi: 10.1038/s41418-019-0466-7. Epub 2019 Dec 4. Cell Death Differ. 2020. PMID: 31802036 Free PMC article.

5

GABPA inhibits invasion/metastasis in papillary thyroid carcinoma by regulating DICER1 expression.

Yuan X, Mu N, Wang N, Strååt K, Sofiadis A, Guo Y, Stenman A, Li K, Cheng G, Zhang L, Kong F, Ekblad L, Wennerberg J, Nilsson IL, Juhlin CC, Larsson C, Xu D. Yuan X, et al. Oncogene. 2019 Feb;38(7):965-979. doi: 10.1038/s41388-018-0483-x. Epub 2018 Sep 4. Oncogene. 2019. PMID: 30181547

6

Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy.

Yang MY, Zhao RR, Fang YF, Jiang JL, Yuan XT, Shao JW. Yang MY, et al. Int J Pharm. 2019 Oct 30;570:118663. doi: 10.1016/j.ijpharm.2019.118663. Epub 2019 Sep 4. Int J Pharm. 2019. PMID: 31493497 Review.

7

TERT promoter mutations and GABP transcription factors in carcinogenesis: More foes than friends.

Yuan X, Dai M, Xu D. Yuan X, et al. Cancer Lett. 2020 Nov 28;493:1-9. doi: 10.1016/j.canlet.2020.07.003. Epub 2020 Aug 6. Cancer Lett. 2020. PMID: 32768523 Free article. Review.

8

Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Shao J, Fang Y, Zhao R, Chen F, Yang M, Jiang J, Chen Z, Yuan X, Jia L. Shao J, et al. Among authors: yuan x. Asian J Pharm Sci. 2020 Nov;15(6):685-700. doi: 10.1016/j.ajps.2020.03.001. Epub 2020 Mar 21. Asian J Pharm Sci. 2020. PMID: 33363625 Free PMC article. Review.

9

Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review.

Yuan X, Liu T, Xu D. Yuan X, et al. Ann Transl Med. 2020 Oct;8(19):1244. doi: 10.21037/atm-20-5024. Ann Transl Med. 2020. PMID: 33178776 Free PMC article. Review.

10

PLEKHS1 Over-Expression is Associated with Metastases and Poor Outcomes in Papillary Thyroid Carcinoma.

Xing X, Mu N, Yuan X, Wang N, Juhlin CC, Strååt K, Larsson C, Xu D. Xing X, et al. Among authors: yuan x. Cancers (Basel). 2020 Jul 31;12(8):2133. doi: 10.3390/cancers12082133. Cancers (Basel). 2020. PMID: 32752127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results